HOSPITAL AUTHORITY OF WAYNE COUNTY v. AMERISOURCEBERGEN DRUG CORPORATION

317 Ga. 182
CourtSupreme Court of Georgia
DecidedAugust 21, 2023
DocketS23Q0486
StatusPublished
Cited by2 cases

This text of 317 Ga. 182 (HOSPITAL AUTHORITY OF WAYNE COUNTY v. AMERISOURCEBERGEN DRUG CORPORATION) is published on Counsel Stack Legal Research, covering Supreme Court of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HOSPITAL AUTHORITY OF WAYNE COUNTY v. AMERISOURCEBERGEN DRUG CORPORATION, 317 Ga. 182 (Ga. 2023).

Opinion

317 Ga. 182 FINAL COPY

S23Q0486. HOSPITAL AUTHORITY OF WAYNE COUNTY v. AMERISOURCEBERGEN DRUG CORPORATION et al.

MCMILLIAN, Justice.

The United States District Court for the Northern District of

Ohio (the “District Court”) has certified two questions to this Court

regarding whether a state entity can continue asserting claims

against opioid manufacturers and distributors after the State of

Georgia entered into a settlement with the pharmaceutical

companies, and as part of the settlement, the General Assembly

enacted OCGA § 10-13B-1 et seq. (the “Settlement Act”) in 2022,

which includes a litigation preemption provision that “bar[s] any

and all past, present or future claims on behalf of any governmental

entity seeking to recover against any business or person that is a

released entity under the terms of the relevant settlement.” OCGA

§ 10-13B-3 (a) (the “preemption provision”).

On April 16, 2019, before Georgia entered into the state-wide settlement with the pharmaceutical companies, the Hospital

Authority of Wayne County, Georgia (“HAWC”) filed suit against a

number of such entities, seeking to recover unreimbursed amounts

it claims to have expended in treating opioid-dependent patients.

See Hosp. Auth. of Wayne County, Ga. v. Purdue Pharma, L.P. et al.,

Case No. 1:19-OP-45278 (N.D. Ohio). HAWC subsequently chose not

to participate in the state-wide settlement and has not individually

released any of its claims. At some point, HAWC’s litigation was

consolidated, along with over 3,000 other cases, into a federal

multidistrict litigation in the District Court. See In re Nat.

Prescription Opiate Litigation (MDL No. 2804).

On October 12, 2022, seven defendants named in HAWC’s

complaint filed a motion to dismiss HAWC’s claims against them

(the “Motion”), contending that the suit is barred by the preemption

provision.1 HAWC opposed the Motion, arguing that the Settlement

1 The Motion identifies the movants as Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., AmerisourceBergen Corporation, McKesson Corporation, and Cardinal Health, Inc., “as well as any other Released Entities, as that term

2 Act, and in particular, the preemption provision, is unconstitutional

because it takes away HAWC’s right to pursue its already-filed

lawsuit and thus violates the Georgia Constitution’s prohibition

against retroactive laws. See Ga. Const. of 1983, Art. I, Sec. I, Par.

X (“Paragraph X”).2 As required by Fed. Rule Civ. P. 5.1,3 HAWC

served a copy of its opposition brief on the Attorney General for the

State of Georgia, and the District Court invited the Attorney

General to intervene in the proceedings on the motion. The Attorney

General responded by letter, declining to intervene at that time but

requesting that the District Court certify two questions to this Court

concerning the preemption provision’s constitutionality and

is defined in the Settlement Agreements, that have been named as defendants in the Complaint.” The movants will be referred to collectively herein as the “Settling Defendants.” 2 Although OCGA § 10-13B-3 (b) provides that the preemption provision

shall not apply “to a bellwether claim of any governmental entity” that meet certain criteria, the parties agree that HAWC’s litigation has not been identified as a bellwether claim for any purpose. 3 Fed. Rule Civ. P. 5.1 (a) requires that a party who files a pleading

“drawing into question the constitutionality of a . . . state statute” must file a notice of the constitutional challenge and serve the notice on the state attorney general. Under Fed. Rule Civ. P. 5.1 (b), the federal court “must, under 28 U.S.C. § 2403, certify to the appropriate attorney general that a statute has been questioned,” and the attorney general is given 60 days in which to intervene in the action. See Fed. Rule Civ. P. 5.1 (c). 3 HAWC’s authority to challenge it. The District Court certified the

following two questions to this Court by order dated December 27,

2022:

(1) Does [HAWC] have the legal authority to challenge the constitutionality of OCGA § 10-13B-1 et seq.? and (2) Does Article I, Section I, Paragraph X of the Georgia Constitution prohibit [the preemption provision’s] bar of past, present and future claims by governmental entities? 1. Turning to the first question, we consider whether HAWC

has the legal authority to challenge the preemption provision on the

grounds that it violates the bar against retroactive laws in

Paragraph X. The preemption provision reads:

Entry into a state-wide opioid settlement agreement shall serve to bar any and all past, present or future claims on behalf of any governmental entity seeking to recover against any business or person that is a released entity under the terms of the relevant settlement. Such bar shall apply to any and all released claims or suits by any governmental entity created by or pursuant to an Act of the General Assembly, the Constitution, or any department, agency, or authority thereof, for damages, abatement, injunctive or any other relief. No such claim barred by this Code section shall be brought, threatened, asserted or pursued in any way in any court, and any such claim shall be dismissed by the court in which the claim is brought. 4 OCGA § 10-13B-3 (a). In construing this provision, “we must afford

the statutory text its plain and ordinary meaning, we must view the

statutory text in the context in which it appears, and we must read

the statutory text in its most natural and reasonable way, as an

ordinary speaker of the English language would.” Domingue v. Ford

Motor Co., 314 Ga. 59, 61 (2) (875 SE2d 720) (2022) (citation and

punctuation omitted). “When looking for the commonly understood

meaning of a word in statutory text, we generally look to dictionaries

and, if relevant, legal dictionaries from the time the statute was

passed.” Raffensperger v. Jackson, 316 Ga. 383, 394 (4) (b) n.14 (888

SE2d 483) (2023).

Here, it is undisputed that HAWC is a “governmental entity”

and the Settling Defendants are each considered a “released entity”

under the Settlement Act. See OCGA § 10-13B-2 (1) (A)

(“Governmental entity” includes “[t]his state and each of its

departments, agencies, divisions, boards, commissions, authorities,

and instrumentalities.”); OCGA § 10-13B-2 (3) (“‘Released entity’

5 means an entity against which a claim has been released under a

state-wide opioid settlement agreement.”); OCGA § 31-7-72 (a)

(“There is created in and for each county and municipal corporation

of the state a public body corporate and politic to be known as the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

PILATO v. STATE OF GEORGIA (Three Cases)
Supreme Court of Georgia, 2025
Metz v. State
915 S.E.2d 613 (Supreme Court of Georgia, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
317 Ga. 182, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hospital-authority-of-wayne-county-v-amerisourcebergen-drug-corporation-ga-2023.